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The remarkable physicochemical properties of magnetic nanoparticles (MNPs) at the
nanoscale have boosted the development of new and promising strategies for the simultaneous
diagnosis and treatment of diseases, particularly in cancer therapy Ð the so-called theranostic
applications (1). In these strategies, the intrinsic superparamagnetic properties of MNPs have
been exploited to gain access into multifunctional systems able to simultaneously perform
as enhanced magnetic resonance imaging (MRI) contrast agents, efficient nanocarriers for
drug delivery and nanoheaters in magnetic hyperthermia based therapy (2), among others.
Nevertheless, the lack of biocompatibility and haemodynamic studies, hamper the consoli-
dation of the multifunctional nanoparticles as the next generation of therapeutic bio-agents
in medicine. In order to gain deeper insight into the complex nanoparticle-red blood cells
(RBCs) membrane interaction, a novel microfluidic methodology was developed based on the
human RBCs deformability as an indicator of haematological pathologies and disorders (3).
For this purpose, a microfluidic device with a hyperbolic channel based on the extensional
flow approach and a high-speed video microscopy system was used. The microfluidic flow
results revealed the higher accuracy of the novel presented methodology compared to the
traditional tests (haemolysis analysis), since smaller increments in the rigidity of the RBCs can
be detected. The rigidity alterations have been reported to be due to the wrapping of small
MNPs by the bilayer membrane of the RBCs, which is directly related with the MNPs size,
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shape and composition (4). Overall, the proposed microfluidic methodology represents a new
concept for nanomedicine, allowing for a more accurate evaluation of the haemocompatibility
of MNPs targeting clinical applications.
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